Business
Notice of Half-Year Financial Results
Notice of Half-Year Financial Results.
About this update from Faron Pharmaceuticals Oy
[{"type":"text","content":"\n\nFaron Pharmaceuticals Ltd.\n(\"Faron\" or the \"Company\")\n \nFaron Pharmaceuticals\nNotice of Half-Year Financial Results\n \nCompany Announcement, 20 August 2024\n \nTURKU, Finland - Faron Pharmaceuticals Ltd (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company pursuing a CLEVER approach to reprogramming myeloid cells to activate anti-tumor immunity in hematological and solid tumor microenvironments, will report its unaudited half-year financial results for the six months ended June 30, 2024, on Tuesday, 27 August 2024.\n \nA live hybrid briefing and Q&A session for investors, analysts and media will be hosted by Dr. Juho Jalkanen, Chief Executive Officer, and Yrjö Wichmann, Chief Financial Officer, at 08:00 am (EDT) / 13:00 pm (BST) / 15:00 pm (EEST) on Wednesday, 28 August 2024.\n \nWebcast registration link: https://faron.videosync.fi/q2-2024\n \nLive participation\nIn addition to the webcast, there are a number of spaces available to attend the briefing in-person at Studio Eliel in Sanomatalo at Töölönlahdenkatu 2, Helsinki. To register, please contact\[email protected] no later than 10:00 a.m. EEST on Monday, 26 August 2024. Please note that places are limited, and you will receive a separate email confirmation.\n \nThe half-year report, presentation, and a replay of the webcast will be available on the Company's website at www.faron.com/investors.\n \n \nFor more information please contact:\n \nInvestor Contact\nFaron Pharmaceuticals E-mail: [email protected]\n \nMedia Contact\nICR Consilium\nMary-Jane Elliott, David Daley, Lindsey Neville\nPhone: +44 (0)20 3709 5700\nE-mail: [email protected] \n \nCairn Financial Advisers LLP, Nomad\nSandy Jamieson, Jo Turner\nPhone: +44 (0) 207 213 0880\n \nPeel Hunt LLP, Broker\nChristopher Golden, James Steel\nPhone: +44 (0) 20 7418 8900\n \nSisu Partners Oy, Certified Adviser on Nasdaq First North\nJuha Karttunen\nPhone: +358 (0)40 555 4727\nJukka Järvelä\nPhone: +358 (0)50 553 8990\n  ...